Archives

Elliott Management’s Marc Steinberg is joining Honeywell’s board ahead of the industrial company’s breakup. Continue Reading View Comments

• May 28, 2025 06:50 AM PDT
• EODHD

🔎 Nvidia (NVDA): The chip maker will report earnings after markets close, in a highly anticipated event. The stock often sees violent post-earnings swings. Last month, Nvidia said the U.S. had effect...

• May 28, 2025 06:48 AM PDT
• EODHD

Nuclear-power startup Oklo, uranium miner Centrus Energy and the U.S. Navy's main nuclear reactor supplier BWX Technologies were all upgraded Wednesday. Last week President Donald Trump signed multipl...

• May 28, 2025 06:47 AM PDT
• EODHD

Boston Scientific (BSX) said Wednesday it will stop global sales of its Acurate valve systems and ha PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscripti...

• May 28, 2025 06:44 AM PDT
• EODHD

Competition between major banks to attract affluent customers has intensified, with HSBC UK launching a switching incentive for new Premier customers. The promotion rewards new customers with a “VIP s...

• May 28, 2025 06:42 AM PDT
• EODHD

STOCKHOLM, May 28, 2025 /PRNewswire/ -- Boliden is today publishing its report of payments to government agencies in accordance with Swedish Law (2015:812) on the reporting of payments to government a...

• May 28, 2025 06:27 AM PDT
• EODHD

Strive Asset Management and Asset Entities (ASST) announced the signing of a $750M private investment in public equity, with an additional $750M in potential financing available upon the exercise of w...

• May 28, 2025 06:25 AM PDT
• EODHD

Elon Musk's SpaceX faces its latest setback after its Starship rocket lost control in its latest test flight on May 27 and exploded upon reentry, failing to deploy its payload. To watch more expert in...

• May 28, 2025 06:21 AM PDT
• EODHD

WAYNE, Pa., May 28, 2025 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a clinical-stage biopharmaceutical company focused on developing novel product candidates for immuno-inflammator...

• May 28, 2025 06:20 AM PDT
• EODHD

Following FDA approval last year, Illumina's TSO Comprehensive test gains broad payer reimbursement, expanding access to comprehensive genomic profiling to match patients with targeted therapies Illum...

• May 28, 2025 06:15 AM PDT
• EODHD